sábado, 26 de agosto de 2023

Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00145-0/fulltext?dgcid=hubspot_update_feature_updatealerts_langas&utm_campaign=update-langas&utm_medium=email&_hsmi=271628053&_hsenc=p2ANqtz-9EHLEII79Dutg__4SsGHhTWP7--lb0JmwhmCV9gbXXD2NxN2dHHQRwHaaeqZG72YiLy0bACYy-JNvW3xHKb-r5MFuuqQ&utm_content=271609654&utm_source=hs_email

No hay comentarios:

Publicar un comentario